Risk of HIV Escape using Sub-Optimal Antiretroviral Dual or Monotherapy.
- Published in:
- AIDS Reviews, 2016, v. 18, n. 4, p. 223
- By:
- Publication type:
- Article
Works matching IS 11396121 AND DT 2016 AND VI 18 AND IP 4
Results: 8
1
2
Reactivation of Hepatitis B in HIV Patients Treated for Hepatitis C.
- Published in:
- AIDS Reviews, 2016, v. 18, n. 4, p. 222
- By:
- Publication type:
- Article
3
HIV Pre-Exposure Prophylaxis - Is it just about pills?
- Published in:
- AIDS Reviews, 2016, v. 18, n. 4, p. 222
- By:
- Publication type:
- Article
4
HIV and HCV Therapies in 2016: Optimal Regimens.
- Published in:
- AIDS Reviews, 2016, v. 18, n. 4, p. 212
- By:
- Publication type:
- Article
5
Body Fat Changes in People Living with HIV on Antiretroviral Therapy.
- Published in:
- AIDS Reviews, 2016, v. 18, n. 4, p. 198
- By:
- Publication type:
- Article
6
HIV/HCV Coinfection in Taiwan.
- Published in:
- AIDS Reviews, 2016, v. 18, n. 4, p. 193
- By:
- Publication type:
- Article
7
Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?
- Published in:
- AIDS Reviews, 2016, v. 18, n. 4, p. 184
- By:
- Publication type:
- Article
8
Minimal Requirements for Primary HIV Latency Models Based on a Systematic Review.
- Published in:
- AIDS Reviews, 2016, v. 18, n. 4, p. 171
- By:
- Publication type:
- Article